196 related articles for article (PubMed ID: 15567074)
1. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia.
Lawford BR; Young RM; Swagell CD; Barnes M; Burton SC; Ward WK; Heslop KR; Shadforth S; van Daal A; Morris CP
Schizophr Res; 2005 Feb; 73(1):31-7. PubMed ID: 15567074
[TBL] [Abstract][Full Text] [Related]
2. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
Hirvonen MM; Laakso A; Någren K; Rinne JO; Pohjalainen T; Hietala J
Synapse; 2009 Oct; 63(10):907-12. PubMed ID: 19582781
[TBL] [Abstract][Full Text] [Related]
3. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo.
Hirvonen MM; Lumme V; Hirvonen J; Pesonen U; Någren K; Vahlberg T; Scheinin H; Hietala J
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):630-6. PubMed ID: 19285111
[TBL] [Abstract][Full Text] [Related]
4. DRD2 C957T and TaqIA genotyping reveals gender effects and unique low-risk and high-risk genotypes in alcohol dependence.
Swagell CD; Lawford BR; Hughes IP; Voisey J; Feeney GF; van Daal A; Connor JP; Noble EP; Morris CP; Young RM
Alcohol Alcohol; 2012; 47(4):397-403. PubMed ID: 22582185
[TBL] [Abstract][Full Text] [Related]
5. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability.
Xu H; Kellendonk CB; Simpson EH; Keilp JG; Bruder GE; Polan HJ; Kandel ER; Gilliam TC
Schizophr Res; 2007 Feb; 90(1-3):104-7. PubMed ID: 17113268
[TBL] [Abstract][Full Text] [Related]
6. The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.
Smith CT; Dang LC; Buckholtz JW; Tetreault AM; Cowan RL; Kessler RM; Zald DH
Transl Psychiatry; 2017 Apr; 7(4):e1091. PubMed ID: 28398340
[TBL] [Abstract][Full Text] [Related]
7. The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis.
Liu L; Fan D; Ding N; Hu Y; Cai G; Wang L; Xin L; Xia Q; Li X; Xu S; Xu J; Yang X; Zou Y; Pan F
Neurosci Lett; 2014 Nov; 583():43-8. PubMed ID: 25240594
[TBL] [Abstract][Full Text] [Related]
8. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients.
Hoenicka J; Aragüés M; Rodríguez-Jiménez R; Ponce G; Martínez I; Rubio G; Jiménez-Arriero MA; Palomo T;
Acta Psychiatr Scand; 2006 Dec; 114(6):435-8. PubMed ID: 17087792
[TBL] [Abstract][Full Text] [Related]
9. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population.
Monakhov M; Golimbet V; Abramova L; Kaleda V; Karpov V
Schizophr Res; 2008 Mar; 100(1-3):302-7. PubMed ID: 18255274
[TBL] [Abstract][Full Text] [Related]
10. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
[TBL] [Abstract][Full Text] [Related]
11. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.
Okuyama Y; Ishiguro H; Toru M; Arinami T
Biochem Biophys Res Commun; 1999 May; 258(2):292-5. PubMed ID: 10329380
[TBL] [Abstract][Full Text] [Related]
12. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
[TBL] [Abstract][Full Text] [Related]
13. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
[TBL] [Abstract][Full Text] [Related]
14. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism.
Kunii Y; Miura I; Matsumoto J; Hino M; Wada A; Niwa S; Nawa H; Sakai M; Someya T; Takahashi H; Kakita A; Yabe H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():123-8. PubMed ID: 24704945
[TBL] [Abstract][Full Text] [Related]
15. Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia.
Hänninen K; Katila H; Kampman O; Anttila S; Illi A; Rontu R; Mattila KM; Hietala J; Hurme M; Leinonen E; Lehtimäki T
Neurosci Lett; 2006 Oct; 407(3):195-8. PubMed ID: 16973280
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
17. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
[TBL] [Abstract][Full Text] [Related]
18. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population.
Kaneshima M; Higa T; Nakamoto H; Nagamine M
Psychiatry Clin Neurosci; 1997 Dec; 51(6):379-81. PubMed ID: 9472122
[TBL] [Abstract][Full Text] [Related]
19. The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis.
González-Castro TB; Hernández-Díaz Y; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Genis-Mendoza A; Alpuin-Reyes M
Behav Brain Funct; 2016 Nov; 12(1):29. PubMed ID: 27829443
[TBL] [Abstract][Full Text] [Related]
20. [Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].
Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Braga EA; Nosikov VV; Trubnikov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(12):32-5. PubMed ID: 9866157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
